Milrinone Lactate
NDC Package 0703-8008-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Milrinone Lactate is a medication used for the short-term treatment of heart failure. Marketed by Teva Parenteral Medicines, Inc., this product is identified by NDC 0703-8008 and is authorized under FDA application ANDA075852.

Identification & Billing

NDC Package Code
0703-8008-01
Package Description
50 mL in 1 VIAL, SINGLE-DOSE
Product Code
0703-8008
11-Digit Billing Format
00703800801

Clinical Specifications

Proprietary Name
Milrinone Lactate
Dosage Form
-
Usage Information
This medication is used for the short-term treatment of heart failure. It works by making your heart beat stronger and by relaxing certain blood vessels so that the amount of blood that is pumped from the heart is increased. This effect may help with symptoms of heart failure (such as shortness of breath, tiredness).

Regulatory & Marketing

Labeler Name
Teva Parenteral Medicines, Inc.
FDA Application #
ANDA075852
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
06-20-2003
End Marketing Date
04-30-2005
Listing Expiration
04-30-2005
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0703-8008-01 identifies a specific commercial package of 50 ml in 1 vial, single-dose of Milrinone Lactate, labeled by Teva Parenteral Medicines, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Teva Parenteral Medicines, Inc. on June 20, 2003. The current certification is valid through April 30, 2005.

What are the primary indications for this medication?

This medication is used for the short-term treatment of heart failure. It works by making your heart beat stronger and by relaxing certain blood vessels so that the amount of blood that is pumped from the heart is increased. This effect may help with symptoms of heart failure (such as shortness of breath, tiredness).

How is this Teva Parenteral Medicines, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00703800801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0703-8008-01
11-Digit CMS (5-4-2)
00703-8008-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.